Aceprometazine
From Wikipedia, the free encyclopedia
 |
|
|
Aceprometazine
|
|
| Systematic (IUPAC) name | |
| 1-[10-(2-dimethylaminopropyl)phenothiazin-2-yl]ethanone | |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C19H22N2OS |
| Mol. mass | 326.457 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | Hepatic |
| Half life | ? |
| Excretion | Renal and fecal |
| Therapeutic considerations | |
| Pregnancy cat. |
Contraindicated |
| Legal status |
℞ Prescription only |
| Routes | Oral |
Aceprometazine (INN) is a prescription drug with neuroleptic and anti-histamine properties. It is not widely prescribed. It may be used in combination with meprobamate for the treatment of sleep disorders. This combination is available in France under the trade name Mepronizine®.
 |
This psychoactive drug-related article is a stub. You can help Wikipedia by expanding it. |
